MiMedx Group Inc Share Price Nasdaq
Equities
US6024961012
Biotechnology & Medical Research
Sales 2024 * | 357M 28.59B | Sales 2025 * | 403M 32.29B | Capitalization | 925M 74.08B |
---|---|---|---|---|---|
Net income 2024 * | 43M 3.44B | Net income 2025 * | 56M 4.48B | EV / Sales 2024 * | 2.59 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.29 x |
P/E ratio 2024 * |
20.4
x | P/E ratio 2025 * |
16.1
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.76% |
Latest transcript on MiMedx Group Inc
Managers | Title | Age | Since |
---|---|---|---|
Joe Capper
CEO | Chief Executive Officer | 60 | 26/01/23 |
Douglas Rice
DFI | Director of Finance/CFO | 58 | 04/07/23 |
John R. Harper
CTO | Chief Tech/Sci/R&D Officer | - | 31/05/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
William Hawkins
BRD | Director/Board Member | 70 | 01/07/20 |
Phyllis Gardner
BRD | Director/Board Member | 73 | 07/03/21 |
K. Newton
BRD | Director/Board Member | 61 | 18/06/19 |
1st Jan change | Capi. | |
---|---|---|
-20.60% | 128M | |
-7.82% | 67.46M | |
+14.87% | 61.68M | |
+6.64% | 60.58M | |
+0.60% | 51.45M |